On November 6, 2025, Inspire Medical Systems, Inc. announced it expects to release a valuation allowance on its U.S. deferred tax assets, potentially providing an income tax benefit of $90 million to $100 million and increasing earnings per share by $3.00 to $3.30 for the fourth quarter of 2025.